Balog K, Huang AA, Sum SO et al. (2013) A prospective randomized clinical trial of vincristine versus human intravenous immunoglobulin for acute adjunctive management of presumptive primary immune-mediated thrombocytopenia in dogs. Journal of Veterinary Internal Medicine 27, 536–541

Kane BK and Greer RM (2023) Human intravenous immunoglobulin use for hematological immune-mediated disease in dogs. Journal of the American Veterinary Medical Association 261, 1004–1010

Spurlock NK and Prittie JE (2011) A review of current indications, adverse effects, and administration recommendations for intravenous immunoglobulin. Journal of Veterinary Emergency and Critical Care 21, 471–483

Stikeman E and Bianco D (2024) Use of human intravenous immunoglobulin for the treatment of 12 dogs with newly diagnosed malignant disease and presumed secondary immune-mediated thrombocytopenia. Journal of Small Animal Practice 65, 338–345

Zoia A, Busato F and Drigo M (2024) Retrospective evaluation of the short-term response of human intravenous immunoglobulin therapy in the management of canine immune-mediated thrombocytopenia (2010-2015): 27 cases. Journal of Veterinary Emergency and Critical Care (San Antonio) 34, 465–477